Liza Moskowitz Babiskin is a Bethesda, Maryland based female chiropractor who is specialized as General Chiropractor. Active license number of Liza Moskowitz Babiskin as General Chiropractor is S03926 in Maryland. Liza Moskowitz Babiskin is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Liza Moskowitz Babiskin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Gender:
Female
Practice Address:
5415 W Cedar Ln Ste 105b, Bethesda, Maryland, 20814-1515
Phone:
301-530-0802
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1194242073
NPI Enumeration Date:
23 Aug, 2017
NPI Last Update On:
21 Jul, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Liza Moskowitz Babiskin are as mentioned below.
License Number
Specialization
State
Status
S03926
Chiropractor
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5415 W Cedar Ln Ste 105b, Bethesda, Maryland
Zip:
20814-1515
Phone Number:
301-530-0802
Fax Number:
--
Patients can reach Liza Moskowitz Babiskin at 5415 W Cedar Ln Ste 105b, Bethesda, Maryland or can call to book an appointment on 301-530-0802. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.